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Background: In recent decades there has been an increase in the prevalence of allergic disease. Manifestations of
these diseases have allegedly been observed in people living with Human Immunodeficiency Virus (HIV), however,
few studies have been directed at patients under 18 years old. In this context, the aim of this study is to estimate
the prevalence of allergic disease in patients under 18 years old, living with HIV, and to investigate the relationship
between clinico-immunological characteristics of the HIV infection and atopy.
Methods: This is a cross-sectional epidemiological study involving patients under 18 years of age who were followed
up by specialized HIV services in the Southern Region of the State of Santa Catarina, Brazil, from February to October
2012. Data collection tools included a questionnaire established by the International Study of Asthma and Allergy in
Childhood (ISAAC), socio-demographic data, as well as laboratory test results obtained from the medical records. Blood
samples were taken to measure total serum Immunoglobulin E (IgE) levels and a Radioallergosorbent Test (RAST) for
the main aeroallergens. Analysis was performed using Student’s t test, chi-squared, Fisher’s exact and Mann–Whitney
tests, wherever indicated, with p < 0.05 value considered significant.
Results: 29 individuals were evaluated. The prevalence of symptoms of allergic disease was 65.5% (95% CI 56.1-74.8),
the most frequent being rhinitis 44.8% (95% CI 35.0-54.5), followed by asthma 37.9% (95% CI 28.3-47.4) and eczema
27.6% (95% CI 18.8-36.3). RAST was positive in 20.7% of the individuals. There was no significant difference in terms of
total serum IgE between individuals with and without symptoms of allergic disease. Nevertheless, a high frequency of
raised levels of total serum IgE (40.7%) and an association between raised IgE and clinical staging of disease were
observed. A further association between CD8+ cell count and prevalence of symptomatic allergic disease (p = 0.014)
was observed.
Conclusion: There was a high prevalence of reported allergic disease, as well as a high frequency of raised levels of
total serum IgE. The association between CD8+ cell count and the prevalence of symptomatic allergic disease
corroborates studies that demonstrated the role of such cells in the development of allergic disease.Background
Clinical manifestations of allergic disease have been re-
ported in individuals living with Human Immunodefi-
ciency Virus (HIV), such as rhinitis, asthma, cutaneous
rashes consistent with atopic eczema, symptoms of drug
hypersensitivity, and pruritic cutaneous alterations [1-3].
Over the past decades, a global increase has been ob-
served, including in Brazil, in the prevalence of diseases* Correspondence: janedasilva1808@gmail.com
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unless otherwise stated.such as asthma, rhinitis and eczema, particularly in
pediatric patients [4,5]. The clinical and immunological
aspects of HIV-related atopy have been better explored
in cross-sectional studies directed at the adult popula-
tion [6,7]. It seems, however, that atopy in HIV-infected
children may be in part modulated by genetic and envir-
onmental factors, or even by immunological conditions.
It is plausible that reactivity to environmental allergens
may undergo positive and negative modifications associ-
ated with T-helper 2 (Th2)-linked immune changes [8].
On the other hand, when immunological parameters,
such as total serum immunoglobulin E (IgE), are investi-
gated, high levels of this immunoglobulin are found totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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presence of HIV antigen specific IgE [11].
Few international studies are found that specifically ad-
dress HIV in people under 18 years of age. Considering
the diversity of information that can be explored in this
population and the characteristics that every study shows,
further research is needed on this relevant issue. Thus, the
aim of this study was to investigate if symptoms of
asthma, rhinitis and eczema are frequent in HIV-infected
individuals aged 1 to 18 years, in a community in southern
Santa Catarina, Brazil. The purpose was also to evaluate
the association between clinical and immunological char-
acteristics of HIV infection and atopy in this population.
Methods
Study type, location and sample
A cross-sectional epidemiological study was performed on
children and adolescents, aged 1 to 18 years, from 18 muni-
cipalities that form the Association of Municipalities of
Laguna Region (AMUREL), located in southern Santa
Catarina, Brazil [12].
The sample population consisted of 36 individuals liv-
ing with HIV, aged between 1 and 18 years, under regu-
lar follow-up at different specialized HIV services in the
region.
Individuals with a confirmed diagnosis of HIV, with at
least four months of outpatient follow-up, were included.
Individuals were excluded when their parents or guardians
were not interested in taking part in the study or declined
to sign an informed consent form, or if the participants
were using therapeutic drugs that could interfere with the
laboratory results, such immunomodulators, corticoste-
roids, chloroquine and hyperimmune gamma globulin.
Data collection tools
The International Study of Asthma and Allergies in
Childhood (ISAAC) questionnaire was used to investi-
gate allergic disease symptoms (asthma, rhinitis and ec-
zema), which was duly translated into Portuguese and
validated in Brazil [13-15]. The diagnosis of asthma was
based on the occurrence of one of the following: four or
more wheezing attacks in the past year; one to three
wheezing attacks combined with sleep interruption due
to wheezing in the past year; or one to three attacks,
without sleep disturbance, but wheezing following phys-
ical exercise and nocturnal dry cough [16].
The diagnosis of allergic rhinitis was based on symp-
toms of sneezing and rhinorrhea in the past 12 months,
or the presence of itchy-watery eyes with a history of
rhinitis at some time in their life [14].
Eczema was defined as itchy skin patch in flexural
areas, which has waxed and waned over the past
12 months, and having eczema at some point during
their lifetime [15].Additionally, socioeconomic and demographic data, as
well as laboratory test results were collected from the
medical records to complete the investigation.
Supplementary laboratory data
On the day of viral load and CD4+ T-lymphocyte subpop-
ulation count sample collection, an additional blood sam-
ple was taken for the titration of total serum IgE and
radioallergosorbent test (RAST). Total serum IgE meas-
urement was performed using the chemiluminescence im-
munoassay method, for which the detection limits varied
according to the age of the individual, i.e., 1 to 4 years,
351.6 UI/mL; 5 to 10 years, 393.0 UI/mL; 11 to 15 years,
170.0 UI/mL; and over 15 years of age, 165.3 UI/mL.
RAST was performed using the fluoroimmunoassay
technique (ImmunoCap) for the following allergens: dust
mites, cockroaches, animal epithelia, feathers, and fungi.
The degree of sensitization ranged from low to very high
(classes 0 to 6), according to the concentration (KU/L)
of specific IgE to any of the allergens tested.
Statistical analysis
The collected data were stored on a database and analyzed
using GraphPad Prism 6. The D’Agostino test was applied
to evaluate the normal distribution for the studied vari-
ables. Quantitative variables were recorded as mean and
standard deviation in the case of a normal distribution,
and as the median with minimum and maximum values
when the distribution was skewed. Qualitative variables
were presented as absolute values and proportions.
Student’s t test, chi-squared or Fisher’s exact and Mann–
Whitney tests were used according to the nature of the
variables studied, and were considered significant when
p < 0.05.
The Research Ethics Committee of the University of
Southern Santa Catarina (UNISUL) approved this study
(code number 11.060.4.01.III).
Results
Twenty-nine individuals were evaluated. The response
rate was 80.5%. Seven patients did not show interest in
participating in the study, and were excluded. No pa-
tients were using immunomodulators, corticosteroids,
chloroquine or hyperimmune gamma globulin. The
quantitative and qualitative data of the study population
are presented in Tables 1 and 2, respectively.
Based on the responses to the ISAAC questionnaire, 19
individuals confirmed that they had allergic diseases,
which generated a prevalence of 65.5% (95% CI 56.1-74.8).
Symptoms of rhinitis were reported by 44.8% (95% CI
35.0-54.5). A probable diagnosis of asthma was observed
in 37.9% (95% CI 28.3-47.4). Among children under age 3,
who can be considered transient wheezers, only one pre-
sented with symptoms of asthma. Symptoms of eczema














Ul/mln % Abs. mm3
1 16 66 552 743 0.74 <50 1 34 25
2 17 5 633 1743 0.36 <50 2 156 282
3 13 105 293 1132 0.25 20434 1 35 135
4 3 8 1220 1394 0.87 8141 NA NA 547
5 13 150 628 1511 0.41 2489 2 160 493
6 7 86 916 774 1.18 151 NA NA 57
7 12 46 707 1528 0.46 7486 14 868 813
8 3 26 1323 1073 1.23 <50 2 148 31
9 14 11 234 1079 0.21 <50 NA NA 54
10 12 97 525 858 0.61 1437 5 279 NA
11 8 74 845 1190 0.71 <50 NA NA NA
12 4 48 672 1277 0.52 35411 NA NA 49
13 11 107 236 2888 0.08 116038 3 207 30
14 8 95 820 4064 0.20 50179 2 154 28
15 16 22 524 1963 0.26 15001 6 372 70
16 1 6 2474 2193 1.12 54165 NA NA 319
17 12 72 1146 1026 1.11 <50 NA NA 592
18 13 156 983 980 1.00 <50 NA NA 186
19 4 20 418 692 0.60 <50 NA NA 304
20 14 174 1099 1137 0.96 50 2 122 25
21 13 117 346 2225 0.15 50 NA NA 242
22 12 117 571 577 0.98 335 NA NA 42
23 7 60 1913 1266 1.51 50 3 204 128
24 6 16 468 638 0.73 2008 NA NA 382
25 10 117 1173 948 1.23 50 1 82 13
26 13 160 807 896 0.90 125 2 110 380
27 8 19 593 1607 0.36 2671 NA NA 802
28 12 157 974 668 1.45 400 NA NA 1217
29 7 18 974 3439 0.28 50 NA NA 609
Median 12 72 707 1137 0.71 2008 2 155 186
Mean 9.96 74.4 829.8 1431.3 0.71 15081.9 3.3 209.3 290.9
SD 4.32 54.2 488.1 842.4 0.41 28441.5 3.4 209.7 308.5
AMUREL - SC, 2012.
Abs: Absolute Number; Max: maximum; Min: minimum; NA: Not Available, SD: standard deviation.
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trates the distribution of the studied allergic diseases.
The socio-demographic characteristics of the individuals
living with HIV were evaluated. There was no significant
difference between the groups (“yes” vs. “no” responses)
regarding age, gender, ethnicity, family income and num-
ber of people per household. Similarly, there was no differ-
ence between the groups regarding the use of HAART.
Table 3 shows the characteristics of the individuals liv-
ing with HIV, regarding their blood test results and re-
ported allergic diseases.Discussion
Given that 7 patients refused to participate in the study,
it was possible to evaluate 29 individuals. Patients living
with HIV and some health professionals were concerned
about the security of personal information provided to
the researchers, despite clarification of the research pur-
pose and assurance of anonymity. That was the most
common reason underlying the refusal to participate in
the study.
In this population, a high prevalence of reported aller-
gic disease was observed, with 65.5% (95% CI 56.1-74.8)
Table 2 Characteristics of the individuals living with HIV: qualitative data




1 NCa M N 1 - Y
2 Ca M N 1 - N
3 Ca M N 2 - Y
4 Ca F B 1 - Y
5 NCa F A 1 + Y
6 NCa F N 1 + Y
7 Ca F B 1 - Y
8 Ca M C 1 - Y
9 Ca M B 2 + Y
10 Ca M B 1 - Y
11 Ca F B 1 - Y
12 Ca F C 2 - Y
13 Ca M B 2 - Y
14 NCa M N 1 - N
15 NCa M B 1 - N
16 NCa F N 1 - Y
17 Ca F N 1 - Y
18 Ca F B 1 - Y
19 NCa F N 1 - Y
20 Ca M N 1 - Y
21 Ca M B 2 - Y
22 Ca F A 1 - Y
23 Ca F N 1 + Y
24 Ca M A 2 - N
25 Ca F N 1 - Y
26 Ca F A 1 + Y
27 Ca F A 1 - N
28 NCa F A 1 + Y
29 Ca F N 1 - Y
AMUREL - SC, 2012.
Ca: Caucasian, NCa: Non-caucasian; M: Male, F: Female; N: Asymptomatic A: Mild signs and/or symptoms, B: Moderate signs and/or symptoms, C: Severe signs and/
or symptoms; 1: Absent, 2: Moderate, 3: Severe; Y: Yes, N: No; RAST: Radioallergoabsorbent Test.
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allergic diseases investigated. The most frequent symp-
tom was rhinitis, followed by asthma and eczema. Stud-
ies have shown a prevalence of allergic disease in the
pediatric population with HIV that ranged from 10% to
52% [8,9,17-19]. These studies used various methods to
diagnose allergy, including atopy investigation using total
IgE titration [8,17,18], RAST [18] and/or skin patch test-
ing for allergens [8,9,19].
The high prevalence found in the present study may be
due to the method used to investigate allergy. The ISAAC
questionnaire was selected for its standardization, valid-
ation in Brazil, and its high sensitivity and specificity indetecting asthma, rhinitis and eczema [13-15], in addition
to its ease of use. The fact that this method aims to iden-
tify disease based on reporting of symptoms rather than
on medical history and clinical examination, combined
with allergy tests and/or serum IgE testing, may have over-
estimated the prevalence of allergic disease in this popula-
tion. The application of the ISAAC questionnaire in Brazil
revealed that the prevalence rates of allergic diseases
among schoolchildren aged 6-7years and 13–14 years
were lower than those found in our study [4].
A high prevalence of symptoms of asthma, rhinitis and
eczema in individuals living with HIV has been reported
[20]. In a study that evaluated self-reported symptoms of
Figure 1 Distribution of young people (aged 1–18 years) living
with HIV and frequency of reported asthma (A), rhinitis (R) and
eczema (E), according to the allergic disease questionnaire.
∩ = Overlap.
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the study population) of the disease was reported [21].
Amongst children and adolescents living with HIV, the
history of rhinitis was estimated at 60% [19]. Asthma
was also considered a disease of high incidence and
prevalence among children and adolescents living with
HIV, according to other studies [22-24]. Regarding skin
manifestations of HIV infection, eczema has been re-
ported as a rather frequent disease among adults and
children [25-29]. In a study performed on hospital HIV
inpatients and outpatients, a clinical evaluation of 796
cases revealed that 19.2% of them had eczema [27]. It
was found to be the most frequent type of dermatitis
among 70 children with HIV treated at the Tropical
Medicine Foundation of Amazonas, detected in 22.9%
[26]. These studies included a clinical evaluation of the
patients; therefore, they may provide more reliable infor-
mation on the true prevalence of eczema in children
with HIV. Nonetheless, the frequency of 27.6% obtained
in the present study via reporting of symptoms was close
to that number.
Skin tests, as well as allergen-specific IgE via RAST, have
similar sensitivity and diagnostic value in the investigation
of allergic diseases [30,31]. The advantages of the skin testTable 3 Blood sample characteristics of the individuals living
Blood sample
results
Answered “yes” to allergic disease
n = 19 (65.5%)
Median (Min-Max) or Mean ± SD
Eosinophils (Abs.) 180 (110–868)
Eosinophils (%) 2.5 (2–14)
Viral load (copies/ml) 50 (50–3541)
IgE T (UI/mL) 262 (25–813)
CD4+ (cells/mm3) 707 (234–2474)
CD8 + (cells/mm3) 1277 (638–4064)
CD4+/CD8+ ratio 0.61 ± 0.09
(n = 29). Boldface reflects statistical significant difference.are its immediate result and low cost. It does, however, re-
quire an appropriately trained professional to perform and
interpret the results, which was not available at the health
units involved in this study. Therefore, RAST was the pre-
ferred method. RAST-positive individuals accounted for
20.7% of the cases, and 6.9% reported symptoms of aller-
gic disease. However, no significant difference was found
when compared with asymptomatic individuals (13.8%).
The presence of serum IgE or a positive skin test denotes
a status of sensitization. The detection of sensitivity to an
allergen, however, is not equivalent to a clinical diagnosis,
hence the importance of a medical history and knowledge
of the specific characteristics of the disease when choosing
and interpreting test results [32].
There was no significant difference between individ-
uals in terms of total IgE levels. Furthermore, when pa-
tients were divided into groups of raised and normal IgE
levels, the prevalence of allergic disease was not signifi-
cantly different. An increase in IgE levels does not, in
fact, translate into an increase in the prevalence of aller-
gic disease in the context of HIV infection [33]. Al-
though raised total serum IgE may provide information
that corroborates the diagnosis of atopic disease, in HIV
cases this interpretation is more complex due to
cell stimulated IgE production by B lymphocytes, i.e., T
CD4+ lymphocytes or Th are compromised in both
quantity and function. Evaluation of changes in cytokine
profiles for Th1 and Th2 following interaction with viral
proteins is advised to account for the raised levels of
total IgE found in HIV patients [34]. Some studies have
identified high levels of total IgE by age in some HIV-
infected children [11,17,18], including the presence of
specific IgE against HIV antigens [11]. These data sug-
gest that raised total IgE levels in individuals living with
HIV, aged up to 18 years, as well as in some adults living
with HIV [33], may be due to non-specific polyclonal
activation, which is typical of such infection, or in some
cases, as a result of the production of HIV-specific IgE
[11,33].with HIV, according to their reported allergic diseases
Answered “no” to allergic disease p-value
n = 10 (34.5%)







0.90 ± 0.15 0.073
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40.7% of our study population, which corroborates the
findings of other studies that used pediatric populations
with HIV [8,11,17,18]. In addition, the groups with
raised IgE levels presented more clinically advanced
stages than the normal IgE group; however, no difference
was detected in terms of immunological staging. Data
from the literature suggest that there is a direct link be-
tween raised IgE levels and disease progression, both in
adults [33] and children [9,10]. An abnormal synthesis
of IgE during HIV infection may be explained by the
change in the cytokine profile for Th1 and Th2 as the
disease progresses. Cytokines such as interferon gamma
(IFN-y), from the Th1 profile, and interleukin 4 (IL-4),
from the Th2 profile, undergo changes during HIV in-
fection, in which a lower concentration of the latter and
higher concentration of the former is observed. The Th2
profile favors the IgE synthesis, whereas viral proteins
appear to stimulate IgE production by inhibiting the Th1
profile, which inhibits Th2. These changes may become
pronounced in the course of HIV infection [34].
As per other studies performed on individuals aged
under 18 years, this study observed that raised IgE levels
were only related to the clinical stage of disease, which
ranged from absent to severe signs and symptoms. The
defective CD4+ cell function may occur independently
from the clinical stage of HIV disease [35]. Therefore,
the overproduction of IgE in such individuals may be a
reflection of altered CD4+ cell function. Serial IgE mea-
surements in such individuals may be a simple and low-
cost method for monitoring disease progression and
confirming the association detected by such results.
An interesting finding was the significant association be-
tween the CD8+ count and the prevalence of symptoms
of allergic disease (p = 0.014). Published studies have
highlighted the role of CD8+ cells on the physiopathology
of allergic diseases, such as asthma [36,37], eczema [38],
and more recently, rhinitis [39,40]. They report similar
roles for CD8+ and CD4+ cells via the production of cyto-
kines, such as IL-4, or other inflammatory mediators,
which is typical of allergic disease. On the other hand,
lower level of CD8+ cells and higher rates of asthma can
be seen in HIV children undergoing HAART than in those
who do not use HAART [22]. It is possible that the use of
HAART influences the development of asthma, but how
the low level of CD8+ cells can have an influence in this
case is still unknown. In the current study, 6 out of 11 pa-
tients with probable diagnosis of asthma were using
HAART, and the amount of CD8+ cells ranged from 236
cells/mm3 to 707 cells/mm3, whereas in those who did
not use HAART it ranged from 418 cells/mm3 to 2474
cells/mm3 (data not shown).
The literature review did not reveal any published
study that has associated CD8+ count and prevalence ofallergic disease in patients living with HIV. It does, how-
ever, seem logical that there should be an association be-
tween CD8+ cells and raised IgE levels in HIV infection
[41-43]. CD8+ cells could induce IgE synthesis, even in
individuals with a low CD4+ count, due to a subtype of
CD8+ cells, similar to Th2 cells, known as T-cytotoxic 2
(Tc2), and produce cytokines that stimulate the synthesis
of IgE, such as IL-4 [41]. The action of these CD8+ cells
may also occur in allergic diseases [44], although in our
study population no association was detected between
IgE levels and CD8+ count. It is possible that these cells
have played a role at the onset of the allergic disease, via
the release of other mediators that lead to allergic
inflammation.
A limitation of the study was the relatively small sample
size. A robust statistical analysis was not possible to per-
form due to the small number of patients, as well as a few
losses that occurred during the follow-up period. It should
be noted that this appears to be a common issue, which
has been demonstrated by several other studies on chil-
dren and adolescents living with HIV [9,11,17-19]. An-
other limitation was the lack of a control group of
individuals without HIV disease, which would help clarify
the relationship between HIV infection and allergic dis-
eases. The study population was limited to HIV treatment
centers, where no uninfected subject was found, thus
rendering this study into descriptive traits. For that pur-
pose, further studies should be performed on individuals
aged less than 18 years living with HIV, preferably in a
longitudinal follow-up study, with a control group and
large sample.
Conclusion
Symptoms of allergic disease, especially rhinitis, were
often reported by individuals aged 18 years and under liv-
ing with HIV. Furthermore, there was no difference be-
tween allergic and non-allergic patients regarding the
presence of atopy, as evaluated by RAST and total serum
IgE levels; however, a high prevalence of raised IgE levels
was observed in some individuals who presented a signifi-
cantly more advanced clinical stage of the disease than
those with normal IgE. Finally, the association between
CD8+ count and the prevalence of symptoms of allergic
disease (despite the limitations of sample size) corrobo-
rates what has been reported in the literature, which sug-
gests that CD8+ cells play a role in developing these
diseases, including in the context of HIV infection.
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